2022 Kentucky Harm Reduction Summit

2022 HRS - Potential Sequelae of Injection Drug Use

Activity Details
  • Credit Amounts:
    • CME: 1.00
    • CPE: 1.00
    • Other: 1.00
    • EMS: 1.00
    • ASWB ACE: 1.00
    • CNE: 1.00
    • CCHW: 1.00
  • Cost: Free
  • Release: Nov 11, 2022
  • Expires: Nov 10, 2025
  • Estimated Time to Complete:
    1 Hour(s)
  • Average User Rating:
    ( Ratings)


Cheryl E.  Vanderford Cheryl E. Vanderford, MPAS, PA-C
Assistant Professor
Physician Assistant Studies
University of Kentucky
Lexington, Kentucky

Needs Statement

Healthcare teams lack awareness and knowledge about harm reduction services, including 1) prevention and response efforts, 2) available resources, 3) promising practices, 4) disease testing and prevention, 5) addiction and recovery services, 6) local and state partnerships, and 7) the current status of the drug overdose epidemic.

Target Audience

The target audience for this lecture includes physicians, physician assistants, nurse practitioners, nurses, pharmacists, social workers, public health professionals, attorneys, peer support specialists, certified alcohol & drug counselors, community health workers, registered environmental health specialists/registered sanitarians, and any others who might be involved in harm reduction or the treatment of substance use disorders.


Upon completion of this activity, participants will be able to:
1. Describe why it is vital for all healthcare providers to screen for substance use disorders.
2. Identify potential health sequelae of injection drug use.
3. Develop holistic patient-centered treatment plans for persons who inject drugs.


In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral, Kentucky Cabinet for Health and Family Services, Kentucky Income Reinvestment Program (KIRP), Gateway District Health Department, and Kentucky Department for Public Health. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPE Competencies

  • Values/Ethics for Interprofessional Practice
  • Roles/ Responsibilities
  • Interprofessional Communication
  • Teams and Teamwork

This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.

This knowledge-based activity will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 1.00 clinical continuing education credit.

This activity has been approved for 1 hour to meet the continuing education requirements for credential renewal.

This training is approved by the Office of Community Health Workers Program to provide 1.00 continuing education unit for Certified Community Health Workers.

The Kentucky Board of Emergency Medical Services (KBEMS) certifies that this educational activity is designated for 1.00 KBEMS contact hours. KBEMS-2022-UKHCCE-0011

This activity is eligible for up to 1 CEU hours.

UK Healthcare CECentral certifies this activity for 1.00 hour of participation.



Check below to see if your license has SPECIAL INSTRUCTIONS for claiming credit.

  • AMA, ASWB, CNE, CPE, EMS – submit credit as normal.
  • CADC –please choose ‘Other’ credit type to receive a certificate of participation.

  • CCHW – please contact support@cecentral.com for a second & required evaluation. If this second evaluation is not completed, you will not receive CE credit for this event.

  • RS/REHS – please choose ‘Other’ credit type to receive a certificate of participation. Then, submit this certificate to the RS/REHS Board. For questions, please contact rebeccal.gillis@ky.gov or carley.sams@ky.gov.


Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner, free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


This activity is jointly provided by the University of Kentucky, Kentucky Cabinet for Health and Family Services, Kentucky Income Reinvestment Program (KIRP), Gateway District Health Department, and Kentucky Department for Public Health.

In collaboration with Kentucky Aids Education Training Center (KY AETC), Kentucky Injury Prevention and Research Center (KIPRC), Kentucky Mobile Harm Reduction, Kentucky Opioid Response Effort, and Kentucky Department for Public Health Harm Reduction Program.